Summit Therapeutics (SMMT) Revenue Growth (1y) (2018 - 2022)
Summit Therapeutics (SMMT) Revenue Growth (1y) (2018 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Summit Therapeutics | 10.29 Bn | 9.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -83.19% |
| Jun 30, 2022 | 312.28% |
| Mar 31, 2022 | 30.21% |
| Dec 31, 2021 | 35.68% |
| Sep 30, 2021 | 623.20% |
| Jun 30, 2021 | -66.47% |
| Mar 31, 2021 | -40.74% |
| Dec 31, 2020 | 100.34% |
| Sep 30, 2020 | 22.30% |
| Mar 31, 2020 | -33.63% |
| Oct 31, 2019 | -82.49% |
| Jul 31, 2019 | -99.68% |
| Oct 31, 2018 | -74.70% |
| Jul 31, 2018 | 725.33% |
| Apr 30, 2018 | 151.77% |